---
figid: PMC4973254__srep30886-f5
figtitle: Predictive Immunohistochemical Markers Related to Drug Selection for Patients
  Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4973254
filename: srep30886-f5.jpg
figlink: /pmc/articles/PMC4973254/figure/f5/
number: F5
caption: '(A) Tyrosine kinase receptors involved in angiogenesis and lymphangiogenesis
  targeted by VEGF signalling pathway inhibitors. Multiple cellular subtypes, including
  endothelial cells, pericytes, tumour cells, fibroblasts and endothelial progenitor
  cells, are implicated in tumour angiogenesis. Signalling through vascular endothelial
  growth factor receptors and platelet-derived growth factor receptors leads to endothelial
  cell growth, migration and survival. Tumour lymphangiogenesis is mainly driven through
  VEGFC/VEGFR3 and PDGF/PDGFR signalling in lymphatic endothelial cells. (B) Biologic
  pathways and markers in renal cell carcinoma: AKT/PKB = akt/protein kinase B (gene);
  ERK = extracellular signal-regulated kinase; GF = growth factor; GFR = growth factor
  receptor; MEK = methyl ethyl ketone.'
papertitle: Predictive Immunohistochemical Markers Related to Drug Selection for Patients
  Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.
reftext: Xin Ma, et al. Sci Rep. 2016;6:30886.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7028882
figid_alias: PMC4973254__F5
figtype: Figure
redirect_from: /figures/PMC4973254__F5
ndex: bbc02c34-df2c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4973254__srep30886-f5.html
  '@type': Dataset
  description: '(A) Tyrosine kinase receptors involved in angiogenesis and lymphangiogenesis
    targeted by VEGF signalling pathway inhibitors. Multiple cellular subtypes, including
    endothelial cells, pericytes, tumour cells, fibroblasts and endothelial progenitor
    cells, are implicated in tumour angiogenesis. Signalling through vascular endothelial
    growth factor receptors and platelet-derived growth factor receptors leads to
    endothelial cell growth, migration and survival. Tumour lymphangiogenesis is mainly
    driven through VEGFC/VEGFR3 and PDGF/PDGFR signalling in lymphatic endothelial
    cells. (B) Biologic pathways and markers in renal cell carcinoma: AKT/PKB = akt/protein
    kinase B (gene); ERK = extracellular signal-regulated kinase; GF = growth factor;
    GFR = growth factor receptor; MEK = methyl ethyl ketone.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Vhl
  - CAH9
  - sima
  - Pten
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - rl
  - ras
  - Ras64B
  - Ras85D
  - gfr
  - nac
  - Ret
  - reticulated
  - reti
  - rets
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - PDGFRB
  - PDGFRA
  - FLT1
  - KDR
  - FLT4
  - VHL
  - CA9
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - KRAS
  - HRAS
  - NRAS
  - RAPGEF5
  - RET
  - Cancer
  - Lung cancer
---
